230 related articles for article (PubMed ID: 25615626)
1. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
Kang D; Choi HJ; Kang S; Kim SY; Hwang YS; Je S; Han Z; Kim JH; Song JJ
Cell Signal; 2015 Apr; 27(4):807-17. PubMed ID: 25615626
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
[TBL] [Abstract][Full Text] [Related]
3. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer.
Okuno M; Adachi S; Kozawa O; Shimizu M; Yasuda I
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805817
[TBL] [Abstract][Full Text] [Related]
5. The Effects of HSP27 on Gemcitabine-Resistant Pancreatic Cancer Cell Line Through Snail.
Zhang S; Zhang XQ; Huang SL; Chen M; Shen SS; Ding XW; Lv Y; Zou XP
Pancreas; 2015 Oct; 44(7):1121-9. PubMed ID: 26348464
[TBL] [Abstract][Full Text] [Related]
6. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.
Zhu W; Li J; Wu S; Li S; Le L; Su X; Qiu P; Hu H; Yan G
Pancreas; 2012 Oct; 41(7):1029-38. PubMed ID: 22617708
[TBL] [Abstract][Full Text] [Related]
7. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
[TBL] [Abstract][Full Text] [Related]
8. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells.
Kuramitsu Y; Wang Y; Taba K; Suenaga S; Ryozawa S; Kaino S; Sakaida I; Nakamura K
Anticancer Res; 2012 Jun; 32(6):2295-9. PubMed ID: 22641665
[TBL] [Abstract][Full Text] [Related]
9. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
[TBL] [Abstract][Full Text] [Related]
10. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
[TBL] [Abstract][Full Text] [Related]
12. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
[TBL] [Abstract][Full Text] [Related]
13. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
[TBL] [Abstract][Full Text] [Related]
14. The significance of phosphorylated heat shock protein 27 on the prognosis of pancreatic cancer.
Okuno M; Yasuda I; Adachi S; Nakashima M; Kawaguchi J; Doi S; Iwashita T; Hirose Y; Kozawa O; Yoshimi N; Shimizu M; Moriwaki H
Oncotarget; 2016 Mar; 7(12):14291-9. PubMed ID: 26895107
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.
Mori-Iwamoto S; Taba K; Kuramitsu Y; Ryozawa S; Tanaka T; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
Pancreas; 2009 Mar; 38(2):224-6. PubMed ID: 19238023
[No Abstract] [Full Text] [Related]
17. Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.
Gong XG; Lv YF; Li XQ; Xu FG; Ma QY
Biol Pharm Bull; 2010; 33(8):1261-7. PubMed ID: 20686216
[TBL] [Abstract][Full Text] [Related]
18. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ
Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
Guo Y; Ziesch A; Hocke S; Kampmann E; Ochs S; De Toni EN; Göke B; Gallmeier E
J Cell Mol Med; 2015 Feb; 19(2):340-50. PubMed ID: 25331547
[TBL] [Abstract][Full Text] [Related]
20. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
Holcomb BK; Yip-Schneider MT; Waters JA; Beane JD; Crooks PA; Schmidt CM
J Gastrointest Surg; 2012 Jul; 16(7):1333-40. PubMed ID: 22618517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
